Abstract
Background: Neocortical neuronal networks produce synchronized gamma frequency oscillations (30-80 Hz) that are critical for processing and integrating cognitive modalities. Experimental studies have demonstrated that, in the presence of an appropriate pharmacological drive, such neuronal network activity is orchestrated by inhibitory mechanisms, notably GABAA receptor mediated events. Within this context, perisomatic targeting fast-spiking parvalbumin-containing (PV+) interneurons are capable of sustaining action potential output in the gamma frequency range. PV+ interneurons entrain the population of neocortical pyramidal neurons via gamma frequency GABAA-mediated IPSPs. This synchronised synaptic activity manifests at a population level as a coherent gamma frequency oscillation recorded as a local field potential (LFP). Kv3-family potassium channels such as Kv3.1 are selectively expressed in PV+ interneurons in the neocortex. Kv3 channels allow fast-spiking PV+ interneurons to fire accurately at high frequencies to orchestrate the activity of neocortical networks. Such high rates of firing, with high temporal accuracy, are required for the generation of neocortical gamma rhythms. Previous studies in patients suffering from schizophrenia1 and putative animal models2 of the condition demonstrate an inability of neocortical networks to generate coherent gamma frequency oscillations. In addition, post-mortem studies using cortical tissue obtained from patients with schizophrenia report reductions in PV and in the expression of Kv3.1 channels in the remaining PV+ interneurons. Methods: Given that pharmacological manipulation of PV+ interneurons is a tangible therapeutic target for schizophrenia, we have examined the effect of a novel class of agents that positively modulate Kv3 channels. Rodent brain slices containing primary auditory neocortex were prepared as previously detailed3. We also used slices of human inferior temporal neocortex obtained from elective neurosurgery. Using kainate (400 nM), persistent gamma frequency oscillations were recorded as LFPs using extracellular microelectrodes, we then applied Kv3 channels positive modulators (AUT1 and AUT6). Results: Application of AUT1 and AUT6 significantly increased the peak power and area power of persistent gamma activity in the auditory cortex. The peak frequency of gamma frequency oscillations was not altered. Similar results were obtained using slices of human inferior temporal neocortex, persistent gamma frequency oscillation elicited by kainate, were also augmented with the addition of AUT1. Discussion: Our results suggest that modulation of Kv3 channels by these novel compounds may have the potential to correct disruptions in neuronal synchronization in schizophrenic patients by augmenting gamma frequency oscillations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.